This book investigates the complex legal and ethical landscape surrounding human embryonic stem cell research, focusing on patentability and morality. It examines the regulatory frameworks in China, the United States, and the European Union, drawing on comparative legal analysis and ethical considerations. The author, Li Jiang, likely utilizes legal scholarship and policy documents to present a nuanced argument about the challenges and potential pathways for regulating this rapidly advancing field.

This work is likely to be of significant interest to legal scholars, bioethicists, and policymakers engaged with the regulation of emerging biotechnologies. The comparative approach suggests a thorough examination of differing legal traditions and ethical viewpoints. The focus on patentability and morality indicates a deep dive into the core challenges of governing stem cell research.